Oxalic Acid

Oxalic Acid

SCHEMBL7988348

CCC(=O)c1ccc(OCCc2c[nH]cn2)cc1.O=C(O)C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.49
MAPT P10636 3/20 0.49
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
HPGD P15428 1/20 0.49
GAA P10253 2/20 0.45
HRH3 Q9Y5N1 6/20 0.43
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381007 0.96 SMN1; SMN2 (0.52) SMN1; SMN2MAPTRAB9ANPC1HPGD
SCHEMBL7977335 0.90 SMN1; SMN2 (0.51) SMN1; SMN2MAPTRAB9ANPC1HPGD
Oxalic Acid SCHEMBL7987116 0.84 L3MBTL1 (0.49) SMN1; SMN2NPC1ALDH1A1L3MBTL1MEN1
SCHEMBL7961178 0.83 HRH3 (0.58) SMN1; SMN2MAPTGAAHRH3ALDH1A1
SCHEMBL4379265 0.81 KMT2A (0.46) SMN1; SMN2MAPTRAB9ANPC1HPGD
SCHEMBL7974811 0.81 TDP1 (0.51) MAPTHRH3ALDH1A1L3MBTL1
SCHEMBL7974440 0.81 GAA (0.56) SMN1; SMN2MAPTHPGDGAAHRH3
SCHEMBL7971202 0.81 MAPT (0.60) SMN1; SMN2MAPTRAB9ANPC1GAA
SCHEMBL7987565 0.80 L3MBTL1 (0.55) SMN1; SMN2MAPTNPC1HRH3ALDH1A1
Oxalic Acid SCHEMBL7990912 0.79 MEN1 (0.47) SMN1; SMN2MAPTHPGDHRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0760811-A1 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H 3? (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1997-03-12 EP claimed
WO-1996029315-A2 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1996-09-26 WO claimed
US-6248765-B1 ANTIINFLAMMATORY AGENTS; HYPOTENSIVE AGENTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (FR) 2001-06-19 US disclosed